Brazil achieves milestone in eliminating lymphatic filariasis

The World Health Organization (WHO) congratulates Brazil for having eliminated lymphatic filariasis as a public health problem.

Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Ulcerative Colitis at the United European Gastroenterology Week 2023 – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Conference/Study results 16.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Presents

October 17, 2023

Drugmaker Pulls Trodelvy’s Bladder Cancer Approval

Sacituzumab govitecan’s (Trodelvy) accelerated approval in urothelial cancer will be voluntarily withdrawn, Gilead Sciences announced on Friday. The decision was made in consultation with the

October 19, 2024

Canada approves AstraZeneca-Merck’s prostate cancer therapy

The trial evaluated Lynparza along with abiraterone versus placebo with abiraterone in male mCRPC patients. Credit: Image Point Fr / Shutterstock.com. AstraZeneca and Merck (MSD)

July 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.